← Leaderboards
Frank Malinowski
Eveliqure Biotechnologies, Gmbh
$11,483,248
Attributed
$11,483,248
Total exposure
1
Grants
1
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants. They are the sole PI on all grants (the two match).
Funding over time
peak $4.7M · FY2020–25$5M$3.8M$2.5M$1.3M$0
'20
'21
'22
'23
'24
'25
Funding mix
By agency
NIH$11,483,248 · 1
By mechanism
N01$11,483,248 · 1
Top collaborators
No co-investigators on record.
Others in their field
Other Emerging Leaders on “Vaccines”
- Bambra Strokes · Ppd Development Lp$526,656,217
- Ethan Dmitrovsky · Leidos Biomedical Research, Inc.$149,372,007
- Kimberly Smith · Ppd Development Lp$115,671,664
- Kevin Urdahl · Seattle Children'S Hospital$85,664,942
- Yunda Huang · Fred Hutchinson Cancer Center$74,099,786
- Ted Ross · University Of Georgia$71,962,304
Research focus
VaccinesAnimal ModelBacterial Antibiotic ResistanceContractsEfficacy EvaluationEfficacy TestingFormulationImmunogenicitySafetyStability TestingToxicologyVaccine DevelopmentAdvanced DevelopmentEmerging Communicable DiseasesResponseCommunicable DiseasesDisease OutbreaksEscherichia ColiNational Institute Of Allergy And Infectious DiseasePriority PathogenCategoriesManufactureBacterial ResistanceVaccine Candidate
Grant awards (6)
Advanced Development of Vaccine Candidates for Antibiotic Resistant Bacteria$4,685,791
N01 · FY2025 · AI · contact PI
Advanced Development of Vaccine Candidates for Antibiotic Resistant Bacteria$198,329
N01 · FY2024 · AI · contact PI
Advanced Development of Vaccines for Antibiotic Resistant Bacteria$3,490,104
N01 · FY2023 · AI · contact PI
Advanced Development of Vaccines for Antibiotic Resistant Bacteria$1,649,387
N01 · FY2022 · AI · contact PI
Advanced Development of Vaccines for Antibiotic Resistant Bacteria$1,244,544
N01 · FY2021 · AI · contact PI
Advanced Development of Vaccines for Antibiotic Resistant Bacteria$215,093
N01 · FY2020 · AI · contact PI